DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia

Translational Psychiatry

Volumn 7, Issue 2, 2017, Pages

  McKinney, B ^a,b   Ding, Y ^c   Lewis, D A ^a,b   Sweet, R A ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 1 ASSOCIATED PROTEIN 2; LONG UNTRANSLATED RNA; PROTEIN; UNCLASSIFIED DRUG; BAIAP2 PROTEIN, HUMAN; DLG1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATIONAL STUDY; DENDRITIC SPINE; DNA METHYLATION; DROSOPHILA; DSM-IV; FEMALE; GENETIC TRANSCRIPTION; HUMAN; LASER CAPTURE MICRODISSECTION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; PROMOTER REGION; SCHIZOPHRENIA; SEX DIFFERENCE; SUPERIOR TEMPORAL GYRUS; AUTOPSY; CASE CONTROL STUDY; GENETICS; PATHOLOGY; PSYCHOSIS; TEMPORAL LOBE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AUTOPSY; CASE-CONTROL STUDIES; DENDRITIC SPINES; DNA METHYLATION; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 85027575917     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2016.297     Document Type: Article

References (72)

1. Lewis DA, Sweet RA. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest 2009; 119: 706-716.
2. Javitt DC, Sweet RA. Auditory dysfunction in schizophrenia: integrating clinical and basic features. Nat Rev Neurosci 2015; 16: 535-550.
3. Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience 2013; 251: 90-107.
4. Moyer CE, Shelton MA, Sweet RA. Dendritic spine alterations in schizophrenia. Neurosci Lett 2015; 601: 46-53.
5. Shelton MA, Newman JT, Gu H, Sampson AR, Fish KN, MacDonald ML et al. Loss of microtubule-associated protein 2 immunoreactivity linked to dendritic spine loss in schizophrenia. Biol Psychiatry 2015; 78: 374-385.
6. Sweet RA, Henteleff RA, Zhang W, Sampson AR, Lewis DA. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 2009; 34: 374-389.
7. Preston GA, Weinberger DR. Intermediate phenotypes in schizophrenia: a selective review. Dialogues Clin Neurosci 2005; 7: 165-179.
8. Bhatt DH, Zhang S, Gan WB. Dendritic spine dynamics. Annu Rev Physiol 2009; 71: 261-282.
9. Balu DT, Coyle JT. Neuronal D-serine regulates dendritic architecture in the somatosensory cortex. Neurosci Lett 2012; 517: 77-81.
10. Balu DT, Li Y, Puhl MD, Benneyworth MA, Basu AC, Takagi S et al. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci U S A 2013; 110: E2400-E2409.
11. Schizophrenia Working Group of the Psychiatric Genomics C. schizophreniaassociated genetic loci. Nature 2014; 511: 421-427.
12. Cahill ME, Remmers C, Jones KA, Xie Z, Sweet RA, Penzes P. Neuregulin1 signaling promotes dendritic spine growth through kalirin. J Neurochem 2013; 126: 625-635.
13. Remmers C, Sweet RA, Penzes P. Abnormal kalirin signaling in neuropsychiatric disorders. Brain Res Bull 2014; 103: 29-38.
14. Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, Shiino T et al. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. Schizophr Bull 2012; 38: 552-560.
15. Russell TA, Blizinsky KD, Cobia DJ, Cahill ME, Xie Z, Sweet RA et al. A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness. Nat Commun 2014; 5: 4858.
16. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179-184.
17. Kang J, Park H, Kim E. IRSp53/BAIAP2 in dendritic spine development, NMDA receptor regulation, and psychiatric disorders. Neuropharmacology 2016; 100: 27-39.
18. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014; 506: 185-190.
19. Poglia L, Muller D, Nikonenko I. Ultrastructural modifications of spine and synapse morphology by SAP97. Hippocampus 2011; 21: 990-998.
20. Sato J, Shimazu D, Yamamoto N, Nishikawa T. An association analysis of synapseassociated protein 97 (SAP97) gene in schizophrenia. J Neural Transm (Vienna) 2008; 115: 1355-1365.
21. Uezato A, Kimura-Sato J, Yamamoto N, Iijima Y, Kunugi H, Nishikawa T. Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia. Behav Brain Funct 2012; 8: 2.
22. Hall J, Trent S, Thomas KL, O'Donovan MC, Owen MJ. Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity. Biol Psychiatry 2015; 77: 52-58.
23. Holtmaat A, Svoboda K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat Rev Neurosci 2009; 10: 647-658.
24. Chen CC, Lu J, Zuo Y. Spatiotemporal dynamics of dendritic spines in the living brain. Front Neuroanat 2014; 8: 28.
25. Penzes P, Buonanno A, Passafaro M, Sala C, Sweet RA. Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders. J Neurochem 2013; 126: 165-182.
26. Chen X, Leischner U, Rochefort NL, Nelken I, Konnerth A. Functional mapping of single spines in cortical neurons in vivo. Nature 2011; 475: 501-505.
27. Jaffe AE, Shin J, Collado-Torres L, Leek JT, Tao R, Li C et al. Developmental regulation of human cortex transcription and its clinical relevance at single base resolution. Nat Neurosci 2015; 18: 154-161.
28. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008; 82: 696-711.
29. Xiao Y, Camarillo C, Ping Y, Arana TB, Zhao H, Thompson PM et al. The DNA methylome and transcriptome of different brain regions in schizophrenia and bipolar disorder. PLoS ONE 2014; 9: e95875.
30. Connor CM, Akbarian S. DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics 2008; 3: 55-58.
31. Hannon E, Spiers H, Viana J, Pidsley R, Burrage J, Murphy TM et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat Neurosci 2016; 19: 48-54.
32. Jaffe AE, Gao Y, Deep-Soboslay A, Tao R, Hyde TM, Weinberger DR et al. Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat Neurosci 2016; 19: 40-47.
33. Numata S, Ye T, Herman M, Lipska BK. DNA methylation changes in the postmortem dorsolateral prefrontal cortex of patients with schizophrenia. Front Genet 2014; 5: 280.
34. Ruzicka WB, Subburaju S, Benes FM. Circuit-and diagnosis-specific DNA methylation changes at gamma-aminobutyric acid-related genes in postmortem human hippocampus in schizophrenia and bipolar disorder. JAMA Psychiatry 2015; 72: 541-551.
35. MacDonald ML, Ding Y, Newman J, Hemby S, Penzes P, Lewis DA et al. Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia. Biol Psychiatry 2015; 77: 959-968.
36. Nestler EJ, Pena CJ, Kundakovic M, Mitchell A, Akbarian S. Epigenetic basis of mental illness. Neuroscientist 2015; 22: 447-463.
37. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548.
38. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 2013; 29: 189-196.
39. Cox TF, Cox MAA. Multidemensional Scaling. 2nd Chapman and Hall/CRC: Boca Raton, FL, 2001.
40. McCarthy NS, Melton PE, Cadby G, Yazar S, Franchina M, Moses EK et al. Metaanalysis of human methylation data for evidence of sex-specific autosomal patterns. BMC Genomics 2014; 15: 981.
41. Yousefi P, Huen K, Dave V, Barcellos L, Eskenazi B, Holland N. Sex differences in DNA methylation assessed by 450 K BeadChip in newborns. BMC Genomics 2015; 16: 911.
42. Xing J, Watkins WS, Shlien A, Walker E, Huff CD, Witherspoon DJ et al. Toward a more uniform sampling of human genetic diversity: a survey of worldwide populations by high-density genotyping. Genomics 2010; 96: 199-210.
43. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol 2013; 14: R115.
44. Akbarian S, Beeri MS, Haroutunian V. Epigenetic determinants of healthy and diseased brain aging and cognition. JAMA Neurol 2013; 70: 711-718.
45. McKinney BC, Lin CW, Oh H, Tseng GC, Lewis DA, Sibille E. Hypermethylation of BDNF and SST genes in the orbital frontal cortex of older individuals: a putative mechanism for declining gene expression with age. Neuropsychopharmacology 2015; 40: 2604-2613.
46. Lewis DA. The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology 2002; 26: 143-154.
47. McCullumsmith RE, Hammond JH, Shan D, Meador-Woodruff JH. Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology 2015; 40: 1307.
48. Kozlenkov A, Roussos P, Timashpolsky A, Barbu M, Rudchenko S, Bibikova M et al. Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites. Nucleic Acids Res 2014; 42: 109-127.
49. Guintivano J, Aryee MJ, Kaminsky ZA. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics 2013; 8: 290-302.
50. Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC et al. Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet 2010; 87: 229-236.
51. Quintero-Rivera F, Sharifi-Hannauer P, Martinez-Agosto JA. Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review. Am J Med Genet A 2010; 152A: 2459-2467.
52. Fourie C, Li D, Montgomery JM. The anchoring protein SAP97 influences the trafficking and localisation of multiple membrane channels. Biochim Biophys Acta 2014; 1838: 589-594.
53. Smrt RD, Zhao X. Epigenetic regulation of neuronal dendrite and dendritic spine development. Front Biol (Beijing) 2010; 5: 304-323.
54. LaPlant Q, Vialou V, Covington HE 3rd, Dumitriu D, Feng J, Warren BL et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat Neurosci 2010; 13: 1137-1143.
55. Janoutova J, Janackova P, Sery O, Zeman T, Ambroz P, Kovalova M et al. Epidemiology and risk factors of schizophrenia. Neuro Endocrinol Lett 2016; 37: 1-8.
56. Aberg KA, McClay JL, Nerella S, Clark S, Kumar G, Chen W et al. Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry 2014; 71: 255-264.
57. Castellani CA, Melka MG, Diehl EJ, Laufer BI, O'Reilly RL, Singh SM. DNA methylation in psychosis: insights into etiology and treatment. Epigenomics 2015; 7: 67-74.
58. Nishioka M, Bundo M, Koike S, Takizawa R, Kakiuchi C, Araki T et al. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet 2013; 58: 91-97.
59. Abdolmaleky HM, Pajouhanfar S, Faghankhani M, Joghataei MT, Mostafavi A, Thiagalingam S. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2015; 168: 687-696.
60. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13: 484-492.
61. Kulis M, Queiros AC, Beekman R, Martin-Subero JI. Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer. Biochim Biophys Acta 2013; 1829: 1161-1174.
62. Lev Maor G, Yearim A, Ast G. The alternative role of DNA methylation in splicing regulation. Trends Genet 2015; 31: 274-280.
63. Kersey PJ, Allen JE, Armean I, Boddu S, Bolt BJ, Carvalho-Silva D et al. Ensembl Genomes 2016: more genomes, more complexity. Nucleic Acids Res 2016; 44: D574-D580.
64. Baubec T, Schubeler D. Genomic patterns and context specific interpretation of DNA methylation. Curr Opin Genet Dev 2014; 25: 85-92.
65. Zhang L, Hsu FC, Mojsilovic-Petrovic J, Jablonski AM, Zhai J, Coulter DA et al. Structure-function analysis of SAP97, a modular scaffolding protein that drives dendrite growth. Mol Cell Neurosci 2015; 65: 31-44.
66. Zhou W, Zhang L, Guoxiang X, Mojsilovic-Petrovic J, Takamaya K, Sattler R et al. GluR1 controls dendrite growth through its binding partner, SAP97. J Neurosci 2008; 28: 10220-10233.
67. Villegas VE, Zaphiropoulos PG. Neighboring gene regulation by antisense long non-coding RNAs. Int J Mol Sci 2015; 16: 3251-3266.
68. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N et al. Schizophrenia risk from complex variation of complement component 4. Nature 2016; 530: 177-183.
69. Datta D, Arion D, Corradi JP, Lewis DA. Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia. Biol Psychiatry 2015; 78: 775-785.
70. Kozlenkov A, Wang M, Roussos P, Rudchenko S, Barbu M, Bibikova M et al. Substantial DNA methylation differences between two major neuronal subtypes in human brain. Nucleic Acids Res 2016; 44: 2593-2612.
71. Bernard R, Burke S, Kerman IA. Region-specific in situ hybridization-guided lasercapture microdissection on postmortem human brain tissue coupled with gene expression quantification. Methods Mol Biol 2011; 755: 345-361.
72. Jiang Y, Matevossian A, Huang HS, Straubhaar J, Akbarian S. Isolation of neuronal chromatin from brain tissue. BMC Neurosci 2008; 9: 42.